medigraphic.com
ISSN 1727-897X (Electronic)

2013, Number 5

<< Back Next >>

Medisur 2013; 11 (5)

Characterization of Patients with Helicobacter pylori-Negative Peptic Ulcers

Hernández CR, Noa PG, Domínguez ÁC, Mora DI, Osorio PMF, Pomares PY

Language: Spanish
References: 40
Page: 494-507
PDF size: 236.50 Kb.


ABSTRACT

Background: the rate of Helicobacter pylori-negative ulcers is increasing. Treatment with nonsteroidal anti-inflammatory drugs and other ulcerogenic drugs plays a significant role.
Objective: to characterize patients with Helicobacter pylori-negative peptic ulcer.
Methods: a case series study of patients attended by the Gastroenterology Service of the Hermanos Ameijeiras Hospital was conducted in the year 2009. Demographic, epidemiological, clinical, endoscopic and histological variables were studied. Mean and standard deviation were analyzed; logistic regression, t-Student and Chi-square tests were used.
Results: A total of 269 gastric ulcers, 239 duodenal ulcers and 41 combined were diagnosed; 115 cases were Helicobacter pylori-negative and 434 were positive. Nonsteroidal anti-inflammatory drugs were associated with 33,9 % of H. pylori-negative patients and 22.8% of the positive patients. Ulcerative syndrome occurred in 47 % and 45% in both groups. All H. pylori-negative duodenal ulcers were located in the duodenal bulb as well as 96, 6 % of the positive. The antrum was the most common location for gastric ulcerations (92.3% negative; 90.5% positive). Multiple ulcers predominated in the duodenum while double ulcers prevailed in the stomach, all negative for H.pylori. Antral gastritis predominated (73. 0 % H. pilory- negative), the level of activity was higher in the positive cases (97. 0 %) and intestinal metaplasia was similar for both groups.
Conclusions: in patients with H. pylori-negative peptic ulcer, non-steroidal anti-inflammatory drugs should be taken into consideration as one of the main factors associated with this entity.


REFERENCES

  1. Le TH, Fantry GT. Peptic Ulcer Disease. Gastroenterol Hepatol. 2009 (22): 607-11.

  2. Hernández L, Lazcano E, López Y, Aguilar G. Relevancia de los factores de virulencia del Helicobacter pylori para el desarrollo de vacunas. Salud Pública Mex. 2009 ; 51 (3): 447-54.

  3. Módena JL, Acrani GO, Micas AF, Castro Md, Silveira WD, Módena JL, et al. Correlation between Helicobacter pylori infection, gastric diseases and life habits among patients treated at a university hospital in Southeast Brazil. Braz J Infect Dis. 2007 ; 11 (1): 89-95.

  4. Sari YS, Sander E, Erkan E, Tunali V. Endoscopic diagnoses and CLO test results in 9 239 cases, prevalence of Helicobacter pylori in Istanbul, Turkey. J Gastroenterol Hepatol. 2007 ; 22 (11): 1706-11.

  5. Gutiérrez B, Cavazza ME, Ortiz D, Correnti M, Vidal T, Mégraud F, et al. Seroprevalencia de la infección por Helicobacter pylori en pacientes con gastritis crónica, úlcera duodenal y gástrica. Rev Cubana Invest Bioméd [revista en Internet]. 2008 [ cited 11 Mar 2011 ] ; 27 (2): [aprox. 11p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-03002008000200011.

  6. Piñol Jiménez PF, Paniagua Estévez PM, Gra Oramas B, Reyes de la Cruz M. Helicobacter pylori y lesiones endoscópicas e histológicas en mucosa gástrica de pacientes de 50 años y más. Rev Cubana Med [revista en Internet]. 2008 [ cited 11 Mar 2011]; 27 (2): [aprox. 14p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0034-75232008000200006.

  7. Montes Teves P, Salazar Ventura S, Monge Salgado E. Características de las úlceras gastroduodenales en pacientes con biopsia negativa para Helicobacter pylori. Acta Gastroenterológica Latinoamericana. 2010 ; 140 (1): 40-5.

  8. Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol. 2006 ; 4 (2): 130-42.

  9. Ramsoekh D, van Leerdam ME, Rauws EA, Tytgat GN. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori Infection. Clin Gastroenterol

  10. Pietroiusti A, Forlini A, Magrini A, Galante A, Bergamaschi A. Isolated H. pylori duodenal colonization and idiopathic duodenal ulcers. Ame J Gastroenterol. 2008 ; 103 (1): 55-61.

  11. McColl KE. How I manage H. Pylori -Negative, NSAID/ aspirin-negative peptic ulcers. Am J Gastroenterol. 2009 ; 104 (1): 190-3.

  12. Gutiérrez B, Vidal T, Valmaña CE, Santiesteban N, González N, Leonard I, et al. Primer informe sobre el aislamiento de Helicobacter pylori asociado a enfermedades digestivas en Ciudad de La Habana. Vaccimonitor. 2001; 10 (1): 110-21.

  13. Helicobacter Pylori: ¿El tercer dogma? [Internet]. La Habana: Editorial Ciencias Médicas; 2003. [ cited 23 May 2010 ] Available from: http://www.bvs.sld.cu/libros/helicobacter/complet o.pdf.

  14. González-Carbajal Pascual MG, Sevilla Mederos LF, Grá Oramas B. Alteraciones histológicas de la mucosa gástrica y prevalencia del Helicobacter pylori en pacientes dispépticos. Rev Panam Infectol. 2005 ; 7 (1): 8-15.

  15. Osorio Pagola MF, Olivert Cruz MB, de Pasos Carrazana JL, Ceballos Quiñones AB, Vega Galindo M, Ortega Alvelay A. Caracterización de la infección por Helicobacter pylori en pacientes con úlcera gástrica. Medisur [revista en Internet]. 2009 [cited 23 Ene 2012]; 7 (6): [aprox. 17p]. Available from: http://scielo.sld.cu/scielo.php?pid=S1727-897X20 09000600002&script=sci_arttext.

  16. Gisbert JP, Calvet X. Helicobacter pylori negative duodenal ulcer disease. Aliment Pharmacol Ther. 2009 ; 30 (8): 791-815.

  17. Gisbert JP, Pajares JM. 13C-urea breath test in the management of Helicobacter pylori infection. Dig Liver Dis. 2005 ; 37 (12): 899-06.

  18. Chu KM, Kwok KF, Law S, Wong KH. Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics. World J Gastroenterol. 2005 ; 11 (23): 3518-22.

  19. Mañas MD, Domper A, Albillos A, Hernández A, Carpintero P, Lorente R, et al. Endoscopic follow-up of gastric ulcer in a population at intermediate risk for gastric cancer. Rev Esp Enferm Dig. 2009 ; 101 (5): 317-24.

  20. Nguyen TL, Uchiba T, Tsukamoto Y, Trinh D, Ta L, Mai Bh, et al. Helicobacter pylori infection and gastroduodenal disease in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterology. 2010 ; 10: 114-22.

  21. Ramírez Ramos A, Recavarren Arce S, Arias Stella J, Gilman RH, León Barúa R, Garrido KG, et al. Helicobacter pylori, gastritis crónica, úlcera gástrica y úlcera duodenal: Estudio de 1638 pacientes. Rev Gastroenterol Perú. 1999 ; 19 (3): 115-21.

  22. Yeomans ND. Management of peptic ulcer disease not related to Helicobacter. J Gastroenterol Hepatol. 2002 ; 17: 488-94.

  23. Ong TZ, Hawkey CJ, Ho KY. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. J Clin Gastroenterol. 2006 ; 40 (9): 795-800.

  24. Chen TS, Chang FY. Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease. Hepatogastroenterology. 2008 ; 55 (86-87): 1615-8.

  25. McColl KE, Nujumi AM, Chittajallu RS, Dahill S W , Dorrian CA, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut. 1993 ; 34 (6): 762-8.

  26. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002 ; 97 (12): 2950-61.

  27. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000 ; 173 (10): 515-9.

  28. González-Carbajal Pascual MG, Ospina CA, Sandoval FJ, Castellanos FM, Ávalos GR. Influencia de la ingestión de bebidas alcohólicas y del Helicobacter pylori en la gastritis crónica de pacientes alcohólicos. Rev Panam Infectol. 2004 ; 6 (3): 13-8.

  29. Bytzer P, Teglbjaerg PS; Danish Ulcer Study Group. Helicobacter pylori–negative duodenal ulcers: prevalence, clinical characteristics, and prognosis—results from a randomized trial with 2-year follow-up. Am J Gastroenterol. 2001 ; 96 (5): 1409-16.

  30. Kim DJ, Kim HY, Kim SJ, Hahn TH, Jang MK, Baik GH, et al. Helicobacter pylori Infection and Peptic Ulcer Disease in Patients with Liver Cirrhosis. Korean J Intern Med. 2008 ; 23 (1): 16-21.

  31. Wyszomirska RM, Ribeiro LT, Santos Monteiro J, Pontes de Miranda Vidal B, Melo RM, Miranda CT. Associação entre lesões da mucosa gastroduodenal e Helicobacter Pylori em pacientes com doença hepática crônica. Arq Gastroenterol. 2009 ; 46 (4): 256-60.

  32. Lo GH, Yu HC, Chan YC, Chen WC, Hsu PI, Lin CK, et al. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc. 2005 ; 62 (3): 350-6.

  33. Tseng GY, Lin HJ, Fang CT, Yang HB, Tseng GC, Wang PC, et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther. 2007 ; 26 (6): 925-33.

  34. Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. J Clin Gastroenterol. 2008 ; 42 (6): 744-49.

  35. Shirin H, Leja M, Niv Y. Helicobacter pylori and non-malignant diseases. Helicobacter. 2008 ; 13 (1): 23-7.

  36. Post PN, Kuipers EJ, Meijer GA. Declining incidence of peptic ulcer but not of this complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther. 2006 ; 23 (11): 1587-93.

  37. Lassen A, Hallas J, Schaffalitzky O. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol. 2006 ; 101 (5): 945-53.

  38. Kang HY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci. 2006 ; 51 (12): 3210-5.

  39. Zhang C, Yamada N, Wu YL, Matsuhisa T, Matsukura N. Comparison of Helicobacter pylori infection and mucosal histological features of gastric ulcer patiens with chronic gastritis patients. World J Gastroenterol. 2005 ; 11 (7): 976-81.

  40. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007 ; 133 (2): 659-72.




2020     |     www.medigraphic.com